Healthcare provider profile · identity verified

Thomas Warren Lovinger, MD

Family Practice · LEES SUMMIT, MO · NPI 1962729152

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1054	273
Amlodipine Besylate	Amlodipine Besylate	795	217
Levothyroxine Sodium	Levothyroxine Sodium	639	157
Rosuvastatin Calcium	Rosuvastatin Calcium	606	174
Losartan Potassium	Losartan Potassium	556	148
Lisinopril	Lisinopril	511	139
Metformin Hcl Er	Metformin Hcl	447	123
Pantoprazole Sodium	Pantoprazole Sodium	440	129
Omeprazole	Omeprazole	437	122
Tramadol Hcl	Tramadol Hcl	414	97
Gabapentin	Gabapentin	343	104
Carvedilol	Carvedilol	311	88
Tamsulosin Hcl	Tamsulosin Hcl	271	74
Ozempic	Semaglutide	244	45
Sertraline Hcl	Sertraline Hcl	232	67
Pravastatin Sodium	Pravastatin Sodium	223	64
Hydrochlorothiazide	Hydrochlorothiazide	212	62
Glimepiride	Glimepiride	198	52
Jardiance	Empagliflozin	192	47
Fluticasone Propionate	Fluticasone Propionate	191	76
Metoprolol Succinate	Metoprolol Succinate	184	59
Furosemide	Furosemide	183	56
Metformin Hcl	Metformin Hcl	172	47
Tizanidine Hcl	Tizanidine Hcl	172	62
Trazodone Hcl	Trazodone Hcl	172	60
Finasteride	Finasteride	168	52
Potassium Chloride	Potassium Chloride	166	49
Famotidine	Famotidine	158	50
Alendronate Sodium	Alendronate Sodium	153	49
Allopurinol	Allopurinol	149	40
Simvastatin	Simvastatin	147	42
Eliquis	Apixaban	143	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	136	37
Albuterol Sulfate Hfa	Albuterol Sulfate	127	58
Escitalopram Oxalate	Escitalopram Oxalate	127	39
Duloxetine Hcl	Duloxetine Hcl	125	38
Alprazolam	Alprazolam	112	37
Montelukast Sodium	Montelukast Sodium	110	29
Bupropion Xl	Bupropion Hcl	109	29
Metoprolol Tartrate	Metoprolol Tartrate	109	28
Atenolol	Atenolol	108	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	37
Meloxicam	Meloxicam	102	34
Triamcinolone Acetonide	Triamcinolone Acetonide	99	52
Methylprednisolone	Methylprednisolone	88	67
Donepezil Hcl	Donepezil Hcl	82	18
Citalopram Hbr	Citalopram Hydrobromide	80	23
Ezetimibe	Ezetimibe	77	26
Oxybutynin Chloride	Oxybutynin Chloride	75	23
Spironolactone	Spironolactone	75	25
Clonazepam	Clonazepam	70	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	68	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	20
Arexvy	Rsvpref3 Antigen/As01e/Pf	64	64
Clopidogrel	Clopidogrel Bisulfate	64	20
Synthroid	Levothyroxine Sodium	64	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	60	17
Ropinirole Hcl	Ropinirole Hcl	53	13
Zolpidem Tartrate	Zolpidem Tartrate	53	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	51	45
Doxycycline Hyclate	Doxycycline Hyclate	51	36
Pregabalin	Pregabalin	50	14
Celecoxib	Celecoxib	49	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	13
Nystatin	Nystatin	45	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	13
Farxiga	Dapagliflozin Propanediol	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	42	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	15
Acyclovir	Acyclovir	38	suppressed
Clonidine Hcl	Clonidine Hcl	35	suppressed
Linzess	Linaclotide	34	suppressed
Irbesartan	Irbesartan	33	suppressed
Prednisone	Prednisone	32	25
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Cephalexin	Cephalexin	31	28
Esomeprazole Magnesium	Esomeprazole Magnesium	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	22
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	13
Trulicity	Dulaglutide	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Nitroglycerin	Nitroglycerin	22	suppressed
Carvedilol Er	Carvedilol Phosphate	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Temazepam	Temazepam	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Baclofen	Baclofen	17	suppressed
Lorazepam	Lorazepam	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Azithromycin	Azithromycin	15	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Fluconazole	Fluconazole	14	13
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	13	suppressed
Zoloft	Sertraline Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Estradiol	Estradiol	12	suppressed
Metformin Er Osmotic	Metformin Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Torsemide	Torsemide	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error